Magazine Article | March 1, 2022

We've Moved Forward

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

We might have expected this CMO Leadership Awards issue to focus heavily on the year 3 CE (Covid Era). But what we’ve discovered is this: We’ve moved forward collectively as an industry, despite the COVID circumstances, to re-enter the broader historicism of the year 2022 regarding our drug development and manufacturing outsourcing strategies and tactics. Don’t get me wrong; we will cover the COVID challenge in this issue, for example, via articles such as, “A Better Path For CMO Relationships As The Pandemic Continues.” More so, though, what you’ll read in these pages is the importance of continuing to advance the knowledge, best practices, and strategies of outsourcing we’ve been covering now for nearly a decade in this issue.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader